Compare AMRX & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | ORLA |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.9B |
| IPO Year | N/A | N/A |
| Metric | AMRX | ORLA |
|---|---|---|
| Price | $11.98 | $12.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $13.25 | ★ $27.00 |
| AVG Volume (30 Days) | 1.7M | ★ 2.0M |
| Earning Date | 10-30-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2239.45 |
| EPS | 0.02 | ★ 0.16 |
| Revenue | ★ $2,934,959,000.00 | $772,153,000.00 |
| Revenue This Year | $9.99 | $183.80 |
| Revenue Next Year | $6.67 | $36.88 |
| P/E Ratio | $745.76 | ★ $77.86 |
| Revenue Growth | 9.50 | ★ 145.83 |
| 52 Week Low | $6.69 | $5.03 |
| 52 Week High | $12.68 | $14.36 |
| Indicator | AMRX | ORLA |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 50.21 |
| Support Level | $11.83 | $11.99 |
| Resistance Level | $12.25 | $14.36 |
| Average True Range (ATR) | 0.33 | 0.66 |
| MACD | -0.08 | -0.12 |
| Stochastic Oscillator | 44.31 | 28.45 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.